According to the World Health Organisation (WHO), every country is now affected by counterfeit medicines. Counterfeit medicines pose a high risk for patients as well as manufacturers. Our solutions reduce this risk.
As a result, the European Commission’s Falsified Medicine Directive requires the pharmaceutical industry to employ numerous security measures. In addition to tamper evidence systems, the packaging of prescription medicine must have specific distinguishing features. These include the product code, serial number, batch designation, and expiration date.
Individualized advice
Data security
Access rights